Hanmi To Step Up Global Drug Development As Lilly Returns BTK Rights

 
• By Jung Won Shin
  
Indianapolis - Circa April 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals IV - Image
Lilly Returns Rights To Hanmi's BTK Inhibitor

More from South Korea

More from Focus On Asia